2024 Tandem Meetings | Transplantation & Cellular Therapy Meeting of ASTCT and CIBMTR

2024 Tandem Meetings | Transplantation & Cellular Therapy Meeting of ASTCT and CIBMTR

Stanford has 10 presenters at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meeting of American Society for Transplantation and Cellular Therapy (ASTCT) and Center for International Blood & Marrow Transplant Research (CIBMTR). The conference will take place February 21-24, 2024 at the Henry B. González Convention Center in San Antonio, Texas.

Alice Bertaina

Alice Bertaina, MD, PhD

Basics of Immune Monitoring - What Potential ‘Biomarkers’ Are Present in Literature and Why Has so Little Been Validated in Prospective Trials and Clinical Implementation?

Tuesday, February 20

Enhanced Immune Reconstitution and Reduced GvHD Risk with T-allo10 Infusion Post Aβdepleted-HSCT in Pediatric and Young Adult Patients with Hematologic Malignancies
Wednesday, February 21

Ami Bhatt, MD, PhD

Ami Bhatt, MD, PhD

The Rest of the Microbiome: Beyond the Intestinal Bacteria

Friday, February 23

David Epstein, MD

David Epstein, MD

Challenging Cases in HCT and Cellular Therapy

Thursday, February 22

Matthew Frank, MD, PhD

Matthew Frank, MD, PhD

Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome

Wednesday, February 21

Gary Goldstein, BA

Gary Goldstein, BA

Getting Your Money: Presentation and Panel Discussion on What It Takes to Implement Medicare’s Cost-based Reimbursement for Allogenic SCT

Saturday, February 24

Mark P. Hamilton, MD, PhD

Mark P. Hamilton, MD, PhD

CAR19 Therapy Drives Expansion of Clonal Hematopoiesis and Advanced Cytopenias

Friday, February 23

Absence of Evidence for Pervasive CAR19 Driven T-cell Lymphomagenesis Revealed by Comprehensive Genomic Profiling of an Index Tumor
Saturday, February 24

Everett Meyer, MD

Everett Meyer, MD

A Retrospective Analysis Comparing Orca-T to Post-transplant Cyclophosphamide Based Allogenic Hematopoietic Cell Transplant in Patients with Matched Unrelated Donors Receiving Myeloablative Conditioning

Friday, February 23

Sandra On, PharmD

Sandra On, PharmD

ASH Updates Part 1

Friday, February 23

Liora Michal Schultz, MD

Liora Michal Schultz, MD

NIA Past Recipient

Wednesday, February 21

Melody Smith, MD, MS

Melody Smith, MD, MS

Biology of Relapse After Transplant and Cellular Therapy

Wednesday, February 21